ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)
South Korea
· Delayed Price · Currency is KRW 7,110.00
-140.00 (-1.93%)
At close: Apr 28, 2026
ImmuneOncia Therapeutics Market Cap
ImmuneOncia Therapeutics has a market cap or net worth of 528.73 billion as of April 28, 2026.
Market Cap
528.73B
Enterprise Value
505.36B
Revenue
111.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
7,110.00
Market Cap Chart
Since May 19, 2025, ImmuneOncia Therapeutics's market cap has decreased from 547.53B to 528.73B, a decrease of -3.43%. That is a compound annual growth rate of -3.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 528.73B | -45.25% |
| Dec 30, 2025 | 965.63B | 76.36% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CellBion | 486.96B |
| Samyang Biopharm | 598.59B |
| HEM Pharma | 437.75B |
| Myung In Pharmaceutical LTD. | 827.82B |
| DAE HWA Pharmaceutical | 263.10B |
| NOVAREX | 262.17B |
| GREEN CROSS WellBeing | 251.98B |
| G2GBIO | 1,353.41B |